Therapy dog hailed as primary school's 'secret weapon'
Initially Mrs Bailey wanted to bring Darcy in three days a week, however she said Darcy would skulk at the prospect of being left at homeA therapy dog helping children feel calmer in the classroom has been hailed as a "secret weapon" by a head teacher.
Teachers have found the dog helpful in making children feel more happy and safe when coming to school. The "new member of staff" was originally Mrs Bailey's pet, but after training Darcy and seeing how responsive she was to learning, she came up with the idea of having a school dog. Darcy began working at the primary school as a therapy dog after she was certified and assessed by a clinical animal behaviourist.She said: "I've got people wanting to enrol their children next year and coming into reception... because we are the school with the full-time dog and the parents are really embracing that.
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
UK must not follow Canada's 'aggressive' assisted dying policies, inquiry hearsCanada’s euthanasia system should be a warning sign for other countries considering the move, MPs have been told There are reports people have been offered help to die if they do not have adequate access to social support and care PMGallagher1 reports:
Read more »
NPD1 Plus RvD1 Mediated Ischemic Stroke Penumbra Protection Increases Expression of Pro-homeostatic Microglial and Astrocyte Genes - Cellular and Molecular NeurobiologyNeuroprotection to attenuate or block the ischemic cascade and salvage neuronal damage has been extensively explored for treating ischemic stroke. However, despite increasing knowledge of the physiologic, mechanistic, and imaging characterizations of the ischemic penumbra, no effective neuroprotective therapy has been found. This study focuses on the neuroprotective bioactivity of docosanoid mediators: Neuroprotectin D1 (NPD1), Resolvin D1 (RvD1), and their combination in experimental stroke. Molecular targets of NPD1 and RvD1 are defined by following dose–response and therapeutic window. We demonstrated that treatment with NPD1, RvD1, and combination therapy provides high-grade neurobehavioral recovery and decreases ischemic core and penumbra volumes even when administered up to 6 h after stroke. The expression of the following genes was salient: (a) Cd163, an anti-inflammatory stroke-associated gene, was the most differentially expressed gene by NPD1+RvD1, displaying more than a 123-fold upregulation in the ipsilesional penumbra (Lisi et al., Neurosci Lett 645:106–112, 2017); (b) 100-fold upregulation takes place in astrocyte gene PTX3, a key regulator of neurogenesis and angiogenesis after cerebral ischemia (. Rodriguez-Grande et al., J Neuroinflammation 12:15, 2015); and (c) Tmem119 and P2y12, two markers of homeostatic microglia, were found to be enhanced by ten- and fivefold, respectively (Walker et al. Int J Mol Sci 21:678, 2020). Overall, we uncovered that protection after middle cerebral artery occlusion (MCAo) by the lipid mediators elicits expression of microglia and astrocyte-specific genes (Tmem119, Fcrls, Osmr, Msr1, Cd68, Cd163, Amigo2, Thbs1, and Tm4sf1) likely participating in enhancing homeostatic microglia, modulating neuroinflammation, promoting DAMP clearance, activating NPC differentiation and maturation, synapse integrity and contributing to cell survival. Graphical Abstract
Read more »
Genomic hallmarks and therapeutic implications of G0 cell cycle arrest in cancer - Genome BiologyBackground Therapy resistance in cancer is often driven by a subpopulation of cells that are temporarily arrested in a non-proliferative G0 state, which is difficult to capture and whose mutational drivers remain largely unknown. Results We develop methodology to robustly identify this state from transcriptomic signals and characterise its prevalence and genomic constraints in solid primary tumours. We show that G0 arrest preferentially emerges in the context of more stable, less mutated genomes which maintain TP53 integrity and lack the hallmarks of DNA damage repair deficiency, while presenting increased APOBEC mutagenesis. We employ machine learning to uncover novel genomic dependencies of this process and validate the role of the centrosomal gene CEP89 as a modulator of proliferation and G0 arrest capacity. Lastly, we demonstrate that G0 arrest underlies unfavourable responses to various therapies exploiting cell cycle, kinase signalling and epigenetic mechanisms in single-cell data. Conclusions We propose a G0 arrest transcriptional signature that is linked with therapeutic resistance and can be used to further study and clinically track this state.
Read more »
New York smoke: Jodie Comer halts Broadway show due to breathing difficultiesJodie Comer's understudy had to take over during the performance of Prima Facie - after the Liverpudlian began coughing and complaining she could not breathe as New York became enveloped by smoke.
Read more »
Jodie Comer Halts Broadway Performance Amid New York Air CrisisThe Killing Eve actor told audiences at Prima Facie she couldn't breathe, before stopping the play just 10 minutes in.
Read more »
Stay indoors or wear a mask, New Yorkers warned as wildfire smoke blankets cityActor Jodie Comer was forced to abandon a performance of one-woman Broadway play Prima Facie on Wednesday, reportedly complaining 'I can’t breathe in this air' before being helped off stage
Read more »